AxoGen (AXGN) Misses Q1 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.33 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings
• Landstar System (LSTR) PT Raised to $186 at Stifel